Character Biosciences
Jersey City
About Character Biosciences
Character Biosciences is a therapeutics company that uses genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify the molecular drivers of disease progression and develop innovative targeted medicines. Its dedication to patients is reflected in the high standards set to ensure privacy, data security, ethics, scientific rigor, and a meaningful impact on patient health. To enable clinical genomic research, the company collaborates with patients, providers, payers, and scientists to create deeply phenotyped patient cohorts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $137.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2025)
- Website: characterbio.com
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Clinical Trials, Health Care, Health Diagnostics
Canonical: https://fsome.com/organization/character-biosciences-26022 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.